Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12345709
CLAUDIN18 antibodies and methods of treating cancer
granted -
US 12343337
Compounds for increasing neural plasticity
granted -
US 12329776
Treatment methods for ALS patients
granted -
US 12332245
Cancer biomarkers and methods of use thereof
granted -
US 12325755
Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics
granted -
US 12325710
Substituted 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles for treating brain disorders
granted -
US 12325715
Fluorous metal chelates compositions
granted -
US 12318401
Injectable shear-thinning hydrogel containing therapeutic agent for enhanced tumor therapy
granted -
US 12310997
Compositions and methods of treating ocular diseases
granted -
US 12311053
Nanotube-vesicle compositions and uses thereof
granted -
US 12310954
Salivary gland regeneration
granted -
US 12312616
CRISPR-Cas effector polypeptides and methods of use thereof
granted -
US 12311169
Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of locomotion
granted -
US 12313635
Biomarker for thoracic aortic aneurysm
granted -
US 12310934
Methods of treatment of spontaneous preterm birth
granted -
US 12303479
Chloride intracellular channel 1 for regulation of food intake
granted -
US 12297241
Method to engineer transplantable human tissues
granted -
US 12296023
Chemically and photochemically initiated cell membrane blebbing to induce cell vesicle production, modifications thereof, and uses thereof
granted -
US 12297452
Methods or generating T-cells from stem cells and immunotherapeutic methods using the T-cells
granted -
US 12295971
Compositions and methods for enhancing adoptive T cell therapeutics
granted -
US 12292445
Methods of selecting subjects for treatment with metabolomic modulators
granted -
US 12286407
Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases
granted -
US 12285496
Gene therapy for haploinsufficiency
granted -
US 12286480
Modulators of ROR1-ROR2 binding
granted